Table 1 Demographic characteristics of the study cohort
Characteristics | Number | % |
|---|---|---|
All grades | 344 grades | 100.0 |
Age, years (average, standard deviation) | (57.2, 12.8) | |
≤39 | 33 | 9.6 |
40–49 | 78 | 22.7 |
50–59 | 67 | 19.5 |
60–69 | 94 | 27.3 |
70–79 | 68 | 19.8 |
≥80 | 4 | 1.1 |
Sex | ||
Male | 67 | 19.5 |
Female | 277 | 80.5 |
Consulter | ||
Patients | 315 | 91.6 |
Caregiver | 29 | 8.4 |
Cancer type | ||
Breast cancer | 188 | 54.7 |
Pancreatic cancer | 46 | 13.4 |
Ovarian cancer | 29 | 8.4 |
Colorectal cancer | 27 | 7.8 |
Soft tissue sarcoma | 13 | 3.8 |
Gastric cancer | 10 | 2.9 |
Biliary tract cancer | 8 | 2.3 |
Liver cancer | 7 | 2.0 |
Malignant lymphoma | 6 | 1.7 |
Primary unknown cancer | 5 | 1.5 |
Other malignancies | 5 | 1.5 |
Objective of therapy | ||
Adjuvant chemotherapy | 197 | 57.3 |
Palliative chemotherapy | 141 | 41.0 |
Chemotherapy for blood malignancy | 6 | 1.7 |
Grading of adverse event | ||
Grade 1 | 223 | 64.8 |
Grade 2 | 90 | 26.2 |
Grade 3 | 31 | 9.0 |